Last reviewed · How we verify
vaccine with gelatin
A vaccine formulation that uses gelatin as an excipient to stimulate immune response against infectious disease pathogens.
A vaccine formulation that uses gelatin as an excipient to stimulate immune response against infectious disease pathogens. Used for Infectious disease prevention (specific indication unknown without product specification).
At a glance
| Generic name | vaccine with gelatin |
|---|---|
| Sponsor | Beijing Center for Disease Control and Prevention |
| Drug class | vaccine |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Mechanism of action
Vaccines work by presenting antigens to the immune system to generate protective antibody and cellular immune responses. Gelatin serves as a stabilizer and excipient in the vaccine formulation to maintain antigen integrity and improve shelf stability. The specific pathogen target and immune mechanism depend on the particular vaccine antigen contained in this Beijing CDC product.
Approved indications
- Infectious disease prevention (specific indication unknown without product specification)
Common side effects
- Injection site pain or swelling
- Fever
- Myalgia
- Fatigue
Key clinical trials
- Durability of Vaccine Responses (PHASE4)
- Effect of Oral Supplements for Influenza Vaccine Response (NA)
- Influenza Virus Vaccine Plus Vitamin A and D Supplements for Prevention of Respiratory Virus Infections in Children (PHASE2)
- Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy. (PHASE3)
- A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED) (PHASE3)
- Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without Gelatin (PHASE4)
- Phase I Trial Evaluating Safety and Tolerability of CAIV-T in Healthy Japanese Male Adults (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- vaccine with gelatin CI brief — competitive landscape report
- vaccine with gelatin updates RSS · CI watch RSS
- Beijing Center for Disease Control and Prevention portfolio CI